Ubs Group Ag Biotechnology

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
ARMP Armata Pharmaceuticals, Inc.	$254M	$0 0.0% of portfolio	44	Q3 2025 Added 4,300.0%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	659,886	Q3 2025 Reduced 23.88%
VACC Vaccitech PLC	$127M	$0 0.0% of portfolio	13	Q3 2025 New
CELUW Celularity Inc Wt Exp 05/24/20	$0	$0 0.0% of portfolio	1,313	Q3 2025 New
IPSC Century Therapeutics, Inc.	$27.7M	$0 0.0% of portfolio	337	Q3 2025 Reduced 98.8%
DRMAW Dermata Therapeutics Inc Wt Ex	$0	$0 0.0% of portfolio	1,279	Q3 2025 Reduced 31.97%
DYAI Dyadic International Inc	$26.1M	$0 0.0% of portfolio	1	Q3 2025 New
IMRN Immuron Limited	$11.8M	$0 0.0% of portfolio	-	Q3 2025 Reduced 88.55%
NERV Minerva Neurosciences, Inc.	$21.9M	$0 0.0% of portfolio	10	Q3 2025 Reduced 98.86%

NAUT Nautilus Biotechnology, Inc.	$227M	$0 0.0% of portfolio	470	Q3 2025 Reduced 97.12%
NRXPW Nrx Pharmaceuticals Inc Wt Exp	$0	$0 0.0% of portfolio	18	Q3 2025 Reduced 98.8%
OCUP Ocuphire Pharma, Inc.	$20.2M	$0 0.0% of portfolio	884	Q3 2025 Reduced 96.86%
ORMP Oramed Pharmaceuticals Inc.	$92.4M	$0 0.0% of portfolio	357	Q3 2025 Reduced 97.21%
PRTC Pure Tech Health PLC	$451M	$0 0.0% of portfolio	20	Q1 2025 Reduced 98.95%
RNXT Renovo Rx, Inc.	$6.8M	$0 0.0% of portfolio	671	Q3 2025 Reduced 97.76%
SABSW Sab Biotherapeutics Inc Wt Exp	$0	$0 0.0% of portfolio	23,414	Q3 2025 New
SRZNW Surrozen Inc Wt Exp 08/01/31 (	$0	$0 0.0% of portfolio	1,389	Q3 2025 Reduced 3.54%

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.

Ubs Group Ag